文章详细信息 关键词: 米非司酮;;蜕膜;;出血;;形态计量学 [gap=719]Keywords: RU486;; Decidua;; Bleeding;; Morphometry
基于8个网页-相关网页
The trial group of 42 cases was treated by Jiliu soup. The control group of 41 cases was treated by Ru486.
方法 将已确诊为子宫肌瘤的患者83例,随机分为试验组42例,口服肌瘤汤;对照组41例,口服米非司酮。
参考来源 - 肌瘤汤治疗子宫肌瘤的临床研究·2,447,543篇论文数据,部分数据来源于NoteExpress
Objective to explore the antitumor mechanisms of mifepristone (RU486).
目的探讨米非司酮(RU486)抗肿瘤作用的机制。
RU486, an antagonist of glucocorticoid receptor (GR), did not affect these effects.
这些作用不能被糖皮质激素受体(GR)拮抗剂ru 486所阻断。
This study presents the effects of RU486 on human chorio-trophoblast and decidual cells.
本文报道RU 486对离体人绒毛膜滋养层、蜕膜细胞的影响。
应用推荐